Finance

Lists
543904:BOM
Mankind Pharma Ltd
₹2 354,80
+1,06%
(+24,70) 1D
15 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 543904...
Open
₹2 376,75
High
₹2 376,75
Low
₹2 323,00
Mkt. cap
970,28 mjd
Avg. vol.
41,38 k
Volume
20,00 k
P/E ratio
47,65
52-wk high
₹2 640,30
52-wk low
₹1 909,90
EPS
₹49,42
No. of employees
20 k
Open
₹2 376,75
High
₹2 376,75
Low
₹2 323,00
Mkt. cap
970,28 mjd
Avg. vol.
41,38 k
Volume
20,00 k
P/E ratio
47,65
52-wk high
₹2 640,30
52-wk low
₹1 909,90
EPS
₹49,42
No. of employees
20 k
News stories
From web sources and news partners
Profile
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications. As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia
About Mankind Pharma Ltd
CEORajeev Juneja | Sheetal Arora
Employees20,5 k
Founded1991
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
36,97 mjd
35,67 mjd
34,43 mjd
40,31 mjd
Cost of goods sold
10,62 mjd
9,78 mjd
11,71 mjd
10,98 mjd
Cost of revenue
10,62 mjd
9,78 mjd
11,71 mjd
10,98 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8,25 mjd
8,24 mjd
15,80 mjd
9,14 mjd
Operating expense
19,35 mjd
18,92 mjd
14,77 mjd
21,02 mjd
Total operating expenses
29,98 mjd
28,70 mjd
26,48 mjd
32,00 mjd
Operating income
7,00 mjd
6,97 mjd
7,95 mjd
8,30 mjd
Other non operating income
918,70 m
727,50 m
-2,31 mjd
450,00 m
EBT including unusual items
6,24 mjd
5,09 mjd
6,59 mjd
7,69 mjd
EBT excluding unusual items
6,24 mjd
6,16 mjd
5,59 mjd
7,69 mjd
Income tax expense
1,04 mjd
951,20 m
997,50 m
1,95 mjd
Effective tax rate
16,64%
18,69%
15,13%
25,39%
Other operating expenses
8,88 mjd
8,46 mjd
-3,26 mjd
9,63 mjd
Net income
5,12 mjd
4,09 mjd
5,54 mjd
5,68 mjd
Net profit margin
13,84%
11,46%
16,10%
14,09%
Earnings per share
12,38
11,99
13,89
13,74
Interest and investment income
-
-
580,50 m
-
Interest expense
-1,70 mjd
-1,57 mjd
-1,36 mjd
-1,10 mjd
Net interest expenses
-1,70 mjd
-1,57 mjd
-778,20 m
-1,10 mjd
Depreciation and amortization charges
2,22 mjd
2,23 mjd
2,23 mjd
2,26 mjd
EBITDA
9,20 mjd
8,42 mjd
9,97 mjd
10,33 mjd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme